iTeos Therapeutics (ITOS) PT Lowered to $42 at Wedbush
Tweet
Share
E-mailGet Alerts ITOS Hot Sheet
Price: $10.15 --0%
Rating Summary:
1 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
1 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
Wedbush analyst David Nierengarten lowered the price target on iTeos Therapeutics (NASDAQ: ITOS) to $42.00 (from $49.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Wolverine World Wide (WWW) PT Raised to $31 at UBS on Growth, EPS Upside Potential
- Liberty Media Corp-Liberty Formula One (FWONA) PT Raised to $124 at Guggenheim
- Adeia (ADEA) PT Raised to $50 at BWS Financial
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
